EMCDDA. New drugs in Europe, 2012, European Monitoring Centre for Drugs and Drug Addiction, Lisbon, 1 May 2013. 773 kB. #24
Hess, C; Murach, J; Krueger, L; Scharrenbroch, L; Unger, M; Madea, B; Sydow, K. Simultaneous detection of 93 synthetic cannabinoids by liquid chromatography-tandem mass spectrometry and retrospective application to real forensic samples. Drug Test. Anal., 1 May 2017, 9 (5), 721-733. 267 kB. https://doi.org/10.1002/dta.2030 #A-796260 LC,MS
Westphal, F; Girreser, U; Knecht, S. Structure elucidation of a new open chain isomer of the cannabimimetic cyclopropoylindole A-796,260. Forensic Sci. Int., 1 Jan 2014, 234, 139-148. 1.1 MB. https://doi.org/10.1016/j.forsciint.2013.11.006 #4
Banister, SD; Connor, M. The chemistry and pharmacology of synthetic cannabinoid receptor agonists as new psychoactive substances: Origins. In New Psychoactive Substances: Pharmacology, Clinical, Forensic and Analytical Toxicology; Maurer, HH; Brandt, SD, Eds., Springer, Berlin, Heidelberg, 1 Jan 2018; pp 165-190. 906 kB. https://doi.org/10.1007/164_2018_143 #55
Abbate, V; Schwenk, M; Presley, BC; Uchiyama, N. The ongoing challenge of novel psychoactive drugs of abuse. Part I. Synthetic cannabinoids (IUPAC Technical Report). Pure Appl. Chem., 28 Aug 2018, 90 (8), 1255–1282. 1.0 MB. https://doi.org/10.1515/pac-2017-0605 #5. A-796260
Poyner, B; Spangler, M; Morris, JA; Stenzel, J. Analytical profile of three cyclopropanoyl indole cannabinoids. JCLIC, 1 Mar 2013, 23 (2-3), 6-13. 1.9 MB. GC,MS,NMR,IR